La COVID prolongada conlleva otro problema: el estigma
MARTES, 29 de noviembre de 2022 (HealthDay News) — Las personas con COVID prolongada se enfrentan a meses o años de una devastadora fatiga, a unas lagunas mentales que entorpecen el pensamiento, o a una aterradora lucha por respirar.Pero también pued…
Learn MoreShortages of Antibiotics, Antivirals Are Making a Tough Illness Season Worse
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report.The antiviral flu drug Tamiflu is in short supply for…
Learn MoreIncrease Seen in Years of Life Lost Per COVID-19 Death in 2021
TUESDAY, Nov. 29, 2022 (HealthDay News) — Compared with 2020, in 2021, there was a 35.7 percent increase in the years of life lost (YLL) per COVID-19 death, according to a research letter study published online Nov. 29 in the Annals of Internal Medic…
Learn MoreLa COVID puede variar durante el embarazo: vacúnese para mantenerse segura
LUNES, 28 de noviembre de 2022 (HealthDay News) — Cuando las mujeres embarazadas contraen la COVID-19, una de cada 10 tendrá síntomas moderados, graves o incluso críticos, encuentra un estudio reciente.Entonces, es importante que se vacunen contra la…
Learn MoreMedical Masks Similar to N95 Respirators for Preventing COVID-19
TUESDAY, Nov. 29, 2022 (HealthDay News) — For health care workers providing care to patients with COVID-19, the risk for COVID-19 does not differ significantly with use of medical masks versus N95 respirators, according to a study published online No…
Learn MoreLong COVID Often Brings Another Issue: Stigma
TUESDAY, Nov. 29, 2022 (HealthDay News) — People with long COVID deal with months or years of punishing fatigue, mind-numbing brain fog or a frightening fight to take each and every breath.But they can also face the skepticism of others, a new study …
Learn MoreStudies Compare Various Treatments for COVID-19
MONDAY, Nov. 28, 2022 (HealthDay News) — Sotrovimab is effective compared with molnupiravir for patients at high risk for severe outcomes from COVID-19; however, there is no difference for angiotensin receptor blockers versus placebo for management o…
Learn MoreNew COVID-19 Variant XBB Gaining Ground Among Americans
MONDAY, Nov. 28, 2022 (HealthDay News) — U.S. health officials are tracking a new COVID-19 variant that is a combination of two earlier omicron subvariants. Known as XBB, this latest subvariant now represents 3.1 percent of new COVID-19 cases through…
Learn MoreLa Casa Blanca vuelve a instar a ponerse los refuerzos contra la COVID, y cita su efectividad
MIÉRCOLES, 23 de noviembre de 2022 (HealthDay News) — No es demasiado tarde para ponerse la vacuna de refuerzo más reciente contra la COVID-19.Ya sea la vacuna bivalente de Pfizer o la de Moderna, los refuerzos ofrecen protección adicional contra la …
Learn MoreLa metformina, un medicamento para la diabetes, podría evitar la COVID grave
MIÉRCOLES, 23 de noviembre de 2022 (HealthDay News) — Un medicamento para la diabetes de un siglo de antigüedad parece ayudar a evitar que los pacientes con COVID-19 de alto riesgo desarrollen una enfermedad letal, informa un nuevo estudio.La metform…
Learn More